The finding may also suggest that IL-6 plays a role in the pathophysiology of T2D, potentially contributing to hyperinsulinemia and perpetuation of the early stages of beta cell hyperfunction in the context of insulin resistance, as well as to β-cell exhaustion and overt diabetes [35,36]. The gene discussed is IL6; the disease is type 2 diabetes mellitus.